Evidence map›Paper›PMID 26908718›Full record

ArticleThe Journal of infectious diseases2016

The Role of the Polio Program Infrastructure in Response to Ebola Virus Disease Outbreak in Nigeria 2014.

Rui G Vaz, Pascal Mkanda, Richard Banda, William Komkech, Olubowale O Ekundare-Famiyesin, Rosemary Onyibe, Sunday Abidoye, Peter Nsubuga, Sylvester Maleghemi, Bolatito Hannah-Murele and 1 more

Open access · hybridAbstract readHistorical Article
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A Risk Analysis Approach to Prioritizing Epidemics: Ebola Virus Disease in West Africa as a Case Study.Risk analysis : an official publication of the Society for Risk Analysis · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Rui G VazWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Pascal MkandaWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Richard BandaWorld Health Organization, Country Representative Office, Abuja, Nigeria.
William KomkechWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Olubowale O Ekundare-FamiyesinWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Rosemary OnyibeWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Sunday AbidoyeWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Peter NsubugaGlobal Public Health Solutions, Atlanta, Georgia.
Sylvester MaleghemiGlobal Public Health Solutions, Atlanta, Georgia.
Bolatito Hannah-MureleWorld Health Organization, Country Representative Office, Abuja, Nigeria.
Sisay G TegegneWorld Health Organization, Country Representative Office, Abuja, Nigeria.
World Health Organization - Nigeria · NGPublic Health Solutions · USWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe current West African outbreak of the Ebola virus disease (EVD) began in Guinea in December 2013 and rapidly spread to Liberia and Sierra Leone. On 20 July 2014, a sick individual flew into Lagos, Nigeria, from Monrovia, Liberia, setting off an outbreak in Lagos and later in Port Harcourt city. The government of Nigeria, supported by the World Health Organization and other partners, mounted a response to the outbreak relying on the polio program experiences and infrastructure. On 20 October 2014, the country was declared free of EVD.

methodsWe examined the organization and operations of the response to the 2014 EVD outbreak in Nigeria and how experiences and support from the country's polio program infrastructure accelerated the outbreak response.

resultsThe deputy incident manager of the National Polio Emergency Operations Centre was appointed the incident manager of the Ebola Emergency Operations Centre (EEOC), the body that coordinated and directed the response to the EVD outbreak in the country. A total of 892 contacts were followed up, and blood specimens were collected from 61 persons with suspected EVD and tested in designated laboratories. Of these, 19 (31%) were positive for Ebola, and 11 (58%) of the case patients were healthcare workers. The overall case-fatality rate was 40%. EVD sensitization and training were conducted during the outbreak and for 2 months after the outbreak ended. The World Health Organization deployed its surveillance and logistics personnel from non-Ebola-infected states to support response activities in Lagos and Rivers states.

conclusionsThe support from the polio program infrastructure, particularly the coordination mechanism adopted (the EEOC), the availability of skilled personnel in the polio program, and lessons learned from managing the polio eradication program greatly contributed to the speedy containment of the 2014 EVD outbreak in Nigeria.

Indexed as

Disease OutbreaksPopulation SurveillanceDisease NotificationHealth PersonnelHemorrhagic Fever, EbolaHistory, 21st CenturyHumansPoliomyelitisEbola virus diseaseNational emergency operation centerNigeriapolio program infrastructure

Identifiers

PMID26908718
PMCPMC4818557
OpenAlexW2274620668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.